Name | 4-Amino-1-cbz-piperidine-4-carboxylic acid |
---|---|
Synonyms |
4-amino-1-phenylmethoxycarbonylpiperidine-4-carboxylic acid
1,4-Piperidinedicarboxylic acid, 4-amino-, 1-(phenylmethyl) ester 4-Amino-1-[(benzyloxy)carbonyl]piperidine-4-carboxylic acid 4-Amino-1-[(benzyloxy)carbonyl]-4-piperidinecarboxylic acid |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 469.0±45.0 °C at 760 mmHg |
Molecular Formula | C14H18N2O4 |
Molecular Weight | 278.304 |
Flash Point | 237.4±28.7 °C |
Exact Mass | 278.126648 |
PSA | 92.86000 |
LogP | 0.99 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.584 |
HS Code | 2933399090 |
---|
~79% 115655-41-9 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2008/14311 A2, 2008 ; Location in patent: Page/Page column 145-146 ; WO 2008/014311 A2 |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |